Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abiomed Inc (ABMD)

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,552,111
  • Shares Outstanding, K 45,296
  • Annual Sales, $ 847,520 K
  • Annual Income, $ 225,530 K
  • 60-Month Beta 1.29
  • Price/Sales 15.93
  • Price/Cash Flow 54.02
  • Price/Book 10.14
Trade ABMD with:

Options Overview

Details
  • Implied Volatility 31.65%
  • Historical Volatility 15.02%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 60.48% on 10/28/20
  • IV Low 31.65% on 06/14/21
  • Put/Call Vol Ratio 0.92
  • Today's Volume 25
  • Volume Avg (30-Day) 204
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 7,928
  • Open Int (30-Day) 8,011

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 1.07
  • Number of Estimates 6
  • High Estimate 1.19
  • Low Estimate 0.99
  • Prior Year 0.58
  • Growth Rate Est. (year over year) +84.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
263.93 +14.45%
on 05/17/21
302.76 -0.23%
on 06/14/21
+33.51 (+12.48%)
since 05/14/21
3-Month
261.27 +15.62%
on 05/14/21
355.94 -15.13%
on 04/23/21
-1.48 (-0.49%)
since 03/12/21
52-Week
234.39 +28.87%
on 06/29/20
387.40 -22.03%
on 01/28/21
+60.39 (+24.99%)
since 06/12/20

Most Recent Stories

More News
Abiomed's (ABMD) preCARDIA Buyout Expands Its Product Portfolio

Abiomed's (ABMD) latest acquisition is expected to improve patient outcome as well as lower the cost of care.

DVA : 120.85 (-1.16%)
ABMD : 304.80 (+1.88%)
HSIC : 77.36 (-1.95%)
VEEV : 304.09 (+1.63%)
Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients

Abiomed (NASDAQ: ABMD) has acquired preCARDIA, developer of a proprietary catheter and controller that will complement Abiomed's product portfolio to expand options for patients with acute decompensated...

ABMD : 304.80 (+1.88%)
Abiomed to Present at Upcoming Investor Conferences

Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at William...

ABMD : 304.80 (+1.88%)
New Strong Sell Stocks for May 4th

ABMD, CLMT, FLMN, GRUB, and IHG have been added to the Zacks Rank #5 (Strong Sell) List on May 4, 2021

IHG : 71.33 (-2.22%)
ABMD : 304.80 (+1.88%)
CLMT : 6.56 (+1.23%)
GRUB : 60.21 (-1.38%)
FLMN : 5.26 (+3.34%)
ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q4

ABIOMED's (ABMD) international and U.S. Impella revenues improve in Q4.

XRAY : 64.40 (-1.78%)
OMI : 47.47 (-0.15%)
ABMD : 304.80 (+1.88%)
COO : 376.18 (+0.26%)
Abiomed: Fiscal Q4 Earnings Snapshot

DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Thursday reported fiscal fourth-quarter earnings of $56.9 million.

ABMD : 304.80 (+1.88%)
Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin

Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported record fourth quarter fiscal 2021 revenue of $241.2 million compared to revenue of $206.7 million...

ABMD : 304.80 (+1.88%)
ABIOMED, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 29, 2021 / ABIOMED, Inc. (NASDAQ:ABMD) will be discussing their earnings results in their 2021 Fourth Quarter Earnings call to be held on April 29, 2021 at 8:00 AM Eastern...

ABMD : 304.80 (+1.88%)
Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella

The final results of the physician-led National Cardiogenic Shock Initiative (NCSI) Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used,...

ABMD : 304.80 (+1.88%)
Dr. Paula A. Johnson Joins Abiomed Board of Directors

Abiomed (NASDAQ:ABMD) announces the appointment of Paula A. Johnson, MD, MPH, to the Abiomed Board of Directors, effective immediately. Dr. Johnson will serve as a member of the Governance and Nominating...

ABMD : 304.80 (+1.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

3rd Resistance Point 303.77
2nd Resistance Point 301.82
1st Resistance Point 300.51
Last Price 304.80
1st Support Level 297.25
2nd Support Level 295.30
3rd Support Level 293.99

See More

52-Week High 387.40
Fibonacci 61.8% 328.95
Fibonacci 50% 310.89
Last Price 304.80
Fibonacci 38.2% 292.84
52-Week Low 234.39

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar